podcastdetails.com

Share

OncoPharm

Mirvetuximab Soravtansine

Listen

Description

A new antibody-drug conjugate is approved for ovarian cancer.

Print Share

Want to check another podcast?

Enter the RSS feed of a podcast, and see all of their public statistics.

Made by Alex Barredo. Send your feedback to alex@barredo.es.